— Know what they know.
Not Investment Advice

CFRXQ OTC

ContraFect Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -98.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 48 · $107 mcap · 11M float · 0.029% daily turnover

Cash Flow Trends

Operating Cash Flow
-$46M -11.8% ▼
Capital Expenditures
$62K +0.0% ▲
Free Cash Flow
-$46M -11.9% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$8M -762.6% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$38M-$13M-$28M-$20M-$65M
Depreciation & Amort.$151K$169K$168K$148K$154K
Stock-Based Comp.$0$1M$3M$3M$4M
Change in Working Capital$2M-$2M-$2M$2M$14M
Other Non-Cash Items$8M-$15M-$6M-$26M$1M
Operating Cash Flow-$26M-$27M-$33M-$41M-$46M
— Investing Activities —
Capital Expenditures-$133K-$20K$0$0-$62K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases-$24M$0-$48M-$49M$0
Investment Sales$41M$22M$20M$37M$32M
Other Investing$0$0$0$0$0
Investing Cash Flow$17M$22M-$27M-$12M$32M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$1M-$2M-$4M-$4M-$851K
Financing Cash Flow$10M$21M$52M$54M$6M
Net Change in Cash$1M$16M-$9M$1M-$8M
Cash End of Period$8M$24M$15M$17M$9M
Free Cash Flow-$26M-$27M-$33M-$41M-$46M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms